About 71% of Medicare Advantage members with prescription drug coverage are enrolled in plans that received four- or five-star quality ratings for 2027, up from approximately 67% for 2026.

An estimated 1.3 million people with intellectual/developmental disabilities (I/DD) lived with a family caregiver age 60 or older in fiscal year 2023. These people represent 17% of the total ...

Clinical artificial intelligence (AI) could potentially handle tasks associated with 16% to 22% of U.S. outpatient billing claims, representing approximately 2 billion to 3 billion claims annually, ...

A Scalable Model For Improved Consumer Engagement: The El Futuro Case Study is starting in ...

The percentage of U.S. high school students reporting poor mental health and suicide risk declined between 2023 and 2025. Students reporting persistent feelings of sadness or hopelessness decreased ...

The percentage of adolescents and adults experiencing a major depressive episode (MDE) declined between 2021 and 2025, according to new federal survey findings. In 2025, approximately 3.7 million ...

California Governor Gavin Newsom approved Assembly Bill 2304, known as Gabriel’s Law, on September 20, 2026, clarifying that county child welfare social workers are subject to existing penalties for ...

Illinois' Department of Children and Family Services (DCFS) is changing how it responds to reports of suspected child abuse or neglect, allowing child protection specialists to assess family safety ...

Michigan Attorney General Dana Nessel filed a lawsuit against Blue Cross Blue Shield of Michigan on October 8, 2026, alleging that the insurer engaged in anticompetitive practices that increased ...

Rhode Island plans to expand its fully integrated dual-eligible special needs plan (FIDE-SNP) program from one health plan to as many as three, creating additional contracting opportunities to serve ...

Medicare Advantage beneficiaries with end-stage kidney disease (ESKD) had a kidney transplant rate approximately 45% lower than beneficiaries with traditional Medicare during the first three years ...

Click Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) clearance of Motivista, a smartphone-based prescription digital therapeutic, on October 5, 2026. It is the first ...